CC100: Safety and Tolerability of Single Doses

NCT02050334 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: CC100
DRUG: Placebo

Sponsor

Chemigen, LLC